CELANESE CORPORATION
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.54B | $10.27B | $10.93B | $9.67B | $8.54B | $5.66B | $6.30B | $7.16B |
| Cost of Revenue | $7.59B | $7.93B | $8.34B | $7.29B | $5.86B | $4.36B | $4.69B | $5.18B |
| Gross Profit | $1.95B | $2.34B | $2.58B | $2.38B | $2.68B | $1.29B | $1.61B | $1.97B |
| Gross Margin | 20.5% | 22.8% | 23.6% | 24.6% | 31.4% | 22.9% | 25.5% | 27.6% |
| Operating Expenses | ||||||||
| Research & Development | $125.0M | $130.0M | $146.0M | $112.0M | $86.0M | $74.0M | $67.0M | $72.0M |
| SG&A Expense | $899.0M | $1.03B | $1.08B | $824.0M | $633.0M | $482.0M | $483.0M | $546.0M |
| Operating Income | $-786.0M | $-720.0M | $1.67B | $1.38B | $1.95B | $664.0M | $834.0M | $1.33B |
| Operating Margin | -8.2% | -7.0% | 15.2% | 14.2% | 22.8% | 11.7% | 13.2% | 18.6% |
| Interest Expense | $701.0M | $676.0M | $720.0M | $405.0M | $91.0M | $109.0M | $115.0M | $125.0M |
| Pretax Income | $-1.22B | $-1.02B | $1.16B | $1.42B | $2.25B | $2.25B | $988.0M | $1.51B |
| Income Tax Expense | $-90.0M | $507.0M | $-795.0M | $-489.0M | $330.0M | $247.0M | $124.0M | $292.0M |
| Net Income | $-1.17B | $-1.54B | $1.94B | $1.89B | $1.89B | $1.99B | $852.0M | $1.21B |
| Net Margin | -12.2% | -15.0% | 17.8% | 19.6% | 22.1% | 35.1% | 13.5% | 16.9% |
| EPS (Basic) | $-10.64 | $-14.11 | $17.85 | $17.48 | $16.99 | $16.85 | $6.88 | $8.99 |
| EPS (Diluted) | $-10.64 | $-14.11 | $17.76 | $17.34 | $16.86 | $16.75 | $6.84 | $8.91 |
| Shares Outstanding (Basic) | 109.5M | 109.3M | 108.8M | 108.4M | 111.2M | 117.8M | 123.9M | 134.3M |
| Shares Outstanding (Diluted) | 109.5M | 109.3M | 109.4M | 109.2M | 112.1M | 118.5M | 124.7M | 135.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |